Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Oikawa

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Diabetes Care|March 5, 2002
T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetesAkira Shimada, Jiro Morimoto, Keiichi Kodama, et al.
Endocrine Journal|October 21, 2016
Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent stateYoichi Oikawa, Hajime Tanaka, Junko Uchida, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Frequency of CTLA-4 gene CT60 polymorphism may not be affected by vitamin D receptor gene Bsm I polymorphism or HLA DR9 in autoimmune-related type 1 diabetes in the JapaneseYasuhiko Kanazawa, Yoshiko Motohashi, Satoru Yamada, et al.
Endocrine Journal|February 15, 2019
Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetesDaigo Saito, Yoichi Oikawa, Gen Mizutani, et al.
Journal of Diabetes Research|April 2, 2016
Diabetic Microangiopathy Is an Independent Predictor of Incident Diabetic Foot UlcerMasuomi Tomita, Yusuke Kabeya, Mari Okisugi, et al.
Clinical Drug Investigation|November 6, 2009
Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary careKen Yajima, Akira Shimada, Hiroshi Hirose, et al.
Journal of Autoimmunity|February 4, 2009
Induction of anti-whole GAD65 reactivity in vivo results in disease suppression in type 1 diabetesYasuhiko Kanazawa, Akira Shimada, Yoichi Oikawa, et al.
Internal Medicine (Tokyo, Japan)|April 19, 2011
Determinants of an optimal response to pioglitazone in terms of HDL-cholesterolYusuke Kabeya, Masuomi Tomita, Yoichiro Asai, et al.
Diabetes Research and Clinical Practice|July 5, 2011
Insulin glulisine may ameliorate nocturnal hypoglycemia related to insulin antibody--a case reportArata Itoh, Yoshifumi Saisho, Masanori Mitsuishi, et al.
Diabetology International|April 25, 2022
Current clinical state of type 1 diabetes in Saitama prefectureYoichi Oikawa, Koshi Hashimoto, Kazuo Hara, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Diabetes Care|March 5, 2002
T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetesAkira Shimada, Jiro Morimoto, Keiichi Kodama, et al.
Endocrine Journal|October 21, 2016
Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent stateYoichi Oikawa, Hajime Tanaka, Junko Uchida, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Frequency of CTLA-4 gene CT60 polymorphism may not be affected by vitamin D receptor gene Bsm I polymorphism or HLA DR9 in autoimmune-related type 1 diabetes in the JapaneseYasuhiko Kanazawa, Yoshiko Motohashi, Satoru Yamada, et al.
Endocrine Journal|February 15, 2019
Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetesDaigo Saito, Yoichi Oikawa, Gen Mizutani, et al.
Journal of Diabetes Research|April 2, 2016
Diabetic Microangiopathy Is an Independent Predictor of Incident Diabetic Foot UlcerMasuomi Tomita, Yusuke Kabeya, Mari Okisugi, et al.
Clinical Drug Investigation|November 6, 2009
Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary careKen Yajima, Akira Shimada, Hiroshi Hirose, et al.
Journal of Autoimmunity|February 4, 2009
Induction of anti-whole GAD65 reactivity in vivo results in disease suppression in type 1 diabetesYasuhiko Kanazawa, Akira Shimada, Yoichi Oikawa, et al.
Internal Medicine (Tokyo, Japan)|April 19, 2011
Determinants of an optimal response to pioglitazone in terms of HDL-cholesterolYusuke Kabeya, Masuomi Tomita, Yoichiro Asai, et al.
Diabetes Research and Clinical Practice|July 5, 2011
Insulin glulisine may ameliorate nocturnal hypoglycemia related to insulin antibody--a case reportArata Itoh, Yoshifumi Saisho, Masanori Mitsuishi, et al.
Diabetology International|April 25, 2022
Current clinical state of type 1 diabetes in Saitama prefectureYoichi Oikawa, Koshi Hashimoto, Kazuo Hara, et al.
Pageof 11